• A Padilla-Serrano, J Galcerá-Tomás, A Melgarejo-Moreno, J M Tenías-Burillo, N Alonso-Fernández, E Andreu-Soler, P Rodríguez-García, M D del Rey-Carrión, A Díaz-Pastor, and J H de Gea-García.
• Unidad Coronaria, Hospital General La Mancha Centro, Alcázar de San Juan, Ciudad Real, España. apadilla@jccm.es
• Med Intensiva. 2013 May 1;37(4):248-58.

ObjectivesTo determine whether there is a linear association of age and aspirin, betablockers, angiotensin-converting enzyme inhibitors and statins; the extent to which elderly patients receive these treatments; and whether age is independently associated with these treatments.DesignA prospective cohort study.SettingCoronary Unit of two hospitals in the Region of Murcia (Spain).PatientsConsecutive patients admitted with the diagnosis of acute myocardial infarction between January 1998 and January 2008.InterventionsNone.Main OutcomesThose related to the administration of aspirin, betablockers, angiotensin-converting enzyme inhibitors and statins during stay in the Coronary Care Unit.ResultsRegarding the remaining patients, octogenarians received a similar proportion of angiotensin-converting enzyme inhibitors (70.8% vs. 69.3%, p=0.41) and less often aspirin (90.4% vs. 94.6%, p<0.001), betablockers (44.4% vs. 69.4%, p<0,001) and statins (47.6% vs. 64.7%, p<0.001). We were only able to demonstrate an abrupt and significant decrease in the use of statins after 80 years of age. Patient age was independently associated with the use of betablockers (OR 0.59; 95%CI 0.47 - 0.73) and statins (OR 0.78; 95%CI 0.65 - 0.95). The lesser administration of these drugs was also associated with early mortality (OR 0.17, 95%CI 0.09 to 0.33 and OR 0.14; 95%CI 0.08 to 0.23, respectively).ConclusionsOctogenarians less often receive aspirin, betablockers and statins, though old age was not an independent factor associated with lesser aspirin use.Copyright © 2012 Elsevier España, S.L. and SEMICYUC. All rights reserved.

13 keywords...

hide…